why choose us

Clinical Trials Search

Showing 13,010 of 132,366 result(s)
Concussion Treatment in Older Adults

Status: Completed

Condition: Concussion, Mild

Interventions: Participants will receive standardized behavioral management strategies for their concussion symptoms including: activity, hydration, nutrition, sleep

Date: 2023-04-13

Mobility Opportunities Via Education;Experience (MOVE): Healthcare Impact Assessment

Status: Completed

Condition: Quality of Life

Interventions: Mobility Opportunities Via Education functional therapy program.

Date: 2023-04-13

Study of RiMO-301 and Radiotherapy With PD-1 Inhibitor for the Treatment of Head-Neck Cancer

Status: Completed

Condition: Head Neck Cancer

Interventions:

A single dose of RiMO-301 will be administered via an intratumoral injection.

PD-1 inhibitor (pembrolizumab or nivolumab) will be administere

Date: 2023-04-13

Study of mRNA-1010 Seasonal Influenza Vaccine in Adults

Status: Completed

Condition: Seasonal Influenza

Interventions: Sterile liquid for injection

Date: 2023-04-13

Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant Recipients

Status: Completed

Condition: Chronic Lung Disease

Interventions:

Date: 2023-04-13

Informational App Development for mHealth for Patient Self-Management of Opioid Use Disorder

Status: ACTIVE_NOT_RECRUITING

Condition: Opioid-Related Disorders

Interventions: The KIOS informational app will contain a user interface that includes a login page, true;false questions for the user to answer, verified public

Date: 2023-04-13

Air Optix Daily Wear Contact Lenses

Status: COMPLETED

Condition: Refractive Errors

Interventions: Commercially available silicone hydrogel contact lenses

Date: 2023-04-13

"Grow Well: Addressing Childhood Obesity in Low-income Families"

Status: Completed

Condition: Diet Habit

Interventions:

  1. the preliminary efficacy of the adapted intervention on mothers' and caregivers' infant feeding knowledge, use of recommended feedin

    Date: 2023-04-13

Ondansetron for the Management of Atrial Fibrillation

Status: Completed

Condition: Atrial Fibrillation

Interventions: Ondansetron 8 mg orally twice daily for 31 days

Date: 2023-04-13

A Study of mRNA-1283.222 Injection Compared With mRNA-1273.222 Injection in Participants ?12 Years of Age to Prevent COVID-19

Status: ACTIVE_NOT_RECRUITING

Condition: COVID-19

Interventions: Sterile liquid for injection

Date: 2023-04-13